| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 28 | 2018 | 3509 | 1.850 |
Why?
|
| Software | 28 | 2019 | 4431 | 1.510 |
Why?
|
| Sequence Analysis, Protein | 8 | 2015 | 261 | 1.120 |
Why?
|
| Neoplasms | 32 | 2018 | 22131 | 0.990 |
Why?
|
| Genomics | 23 | 2017 | 5822 | 0.950 |
Why?
|
| Neoplasm Proteins | 8 | 2017 | 3607 | 0.830 |
Why?
|
| Gene Expression Profiling | 37 | 2017 | 9417 | 0.830 |
Why?
|
| Proteins | 19 | 2019 | 6030 | 0.810 |
Why?
|
| MicroRNAs | 27 | 2016 | 3805 | 0.810 |
Why?
|
| Systems Biology | 5 | 2015 | 481 | 0.800 |
Why?
|
| Databases, Genetic | 13 | 2018 | 1742 | 0.800 |
Why?
|
| Models, Chemical | 2 | 2015 | 611 | 0.780 |
Why?
|
| Programming Languages | 5 | 2015 | 129 | 0.740 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 865 | 0.740 |
Why?
|
| Liposarcoma | 6 | 2013 | 289 | 0.720 |
Why?
|
| Signal Transduction | 33 | 2018 | 23416 | 0.690 |
Why?
|
| Protein Interaction Mapping | 8 | 2015 | 615 | 0.650 |
Why?
|
| Models, Biological | 14 | 2015 | 9461 | 0.650 |
Why?
|
| Gene Regulatory Networks | 11 | 2015 | 1745 | 0.630 |
Why?
|
| DNA Copy Number Variations | 12 | 2016 | 2020 | 0.630 |
Why?
|
| Mutation | 42 | 2018 | 30016 | 0.560 |
Why?
|
| Databases, Protein | 9 | 2018 | 387 | 0.550 |
Why?
|
| Genes, Neoplasm | 5 | 2018 | 370 | 0.530 |
Why?
|
| Models, Genetic | 11 | 2012 | 3431 | 0.530 |
Why?
|
| Cell Respiration | 1 | 2017 | 201 | 0.530 |
Why?
|
| DNA Mutational Analysis | 12 | 2017 | 4110 | 0.520 |
Why?
|
| Evolution, Molecular | 11 | 2018 | 1880 | 0.510 |
Why?
|
| Entropy | 4 | 2016 | 210 | 0.510 |
Why?
|
| Gene Expression Regulation, Neoplastic | 21 | 2018 | 8542 | 0.500 |
Why?
|
| Sequence Alignment | 10 | 2019 | 2178 | 0.480 |
Why?
|
| Indicators and Reagents | 1 | 2014 | 460 | 0.450 |
Why?
|
| Glioblastoma | 9 | 2015 | 3481 | 0.440 |
Why?
|
| Cytological Techniques | 1 | 2015 | 218 | 0.440 |
Why?
|
| RNA, Messenger | 22 | 2017 | 12758 | 0.430 |
Why?
|
| Carcinoma, Renal Cell | 10 | 2017 | 3164 | 0.420 |
Why?
|
| Proteomics | 8 | 2016 | 3836 | 0.420 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 399 | 0.420 |
Why?
|
| Protein Conformation | 10 | 2018 | 3965 | 0.410 |
Why?
|
| Models, Molecular | 13 | 2018 | 5433 | 0.410 |
Why?
|
| Actigraphy | 1 | 2016 | 521 | 0.400 |
Why?
|
| Gene Dosage | 9 | 2017 | 1217 | 0.400 |
Why?
|
| Cell Line, Tumor | 30 | 2018 | 16967 | 0.400 |
Why?
|
| Databases, Factual | 12 | 2017 | 7960 | 0.390 |
Why?
|
| Internet | 17 | 2017 | 3090 | 0.390 |
Why?
|
| User-Computer Interface | 9 | 2017 | 1397 | 0.390 |
Why?
|
| Genome, Human | 13 | 2018 | 4421 | 0.370 |
Why?
|
| RNA, Small Interfering | 8 | 2012 | 3419 | 0.370 |
Why?
|
| Computer Graphics | 5 | 2014 | 340 | 0.370 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 380 | 0.370 |
Why?
|
| Algorithms | 18 | 2018 | 14018 | 0.370 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2014 | 561 | 0.360 |
Why?
|
| Genetic Variation | 7 | 2017 | 6561 | 0.350 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2010 | 110 | 0.340 |
Why?
|
| Drug Resistance | 1 | 2015 | 1594 | 0.330 |
Why?
|
| Gene Expression Regulation | 9 | 2013 | 11874 | 0.330 |
Why?
|
| Metabolomics | 2 | 2018 | 1656 | 0.320 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 933 | 0.320 |
Why?
|
| Oncogenes | 2 | 2018 | 1221 | 0.320 |
Why?
|
| Escherichia coli | 4 | 2018 | 4209 | 0.310 |
Why?
|
| Information Storage and Retrieval | 7 | 2013 | 819 | 0.310 |
Why?
|
| Drug Combinations | 2 | 2015 | 2048 | 0.310 |
Why?
|
| Kidney Neoplasms | 8 | 2017 | 4250 | 0.300 |
Why?
|
| Protein Structure, Tertiary | 8 | 2017 | 3792 | 0.300 |
Why?
|
| Mutation, Missense | 3 | 2014 | 2570 | 0.300 |
Why?
|
| Systems Integration | 6 | 2010 | 426 | 0.290 |
Why?
|
| Gene Silencing | 5 | 2013 | 1503 | 0.290 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2007 | 135 | 0.270 |
Why?
|
| Gene Expression | 5 | 2017 | 7568 | 0.270 |
Why?
|
| Models, Statistical | 5 | 2015 | 5073 | 0.260 |
Why?
|
| Proteome | 6 | 2017 | 1857 | 0.260 |
Why?
|
| Genome | 7 | 2015 | 1737 | 0.260 |
Why?
|
| Ovarian Neoplasms | 6 | 2013 | 4849 | 0.250 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2018 | 509 | 0.250 |
Why?
|
| Humans | 134 | 2018 | 760617 | 0.250 |
Why?
|
| Drug Interactions | 1 | 2010 | 1415 | 0.250 |
Why?
|
| Molecular Sequence Data | 15 | 2017 | 17629 | 0.250 |
Why?
|
| Drug Discovery | 1 | 2013 | 1051 | 0.250 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2018 | 2917 | 0.250 |
Why?
|
| Escherichia coli Proteins | 3 | 2018 | 1064 | 0.240 |
Why?
|
| Arousal | 3 | 2018 | 1171 | 0.240 |
Why?
|
| Antibodies | 1 | 2013 | 2414 | 0.240 |
Why?
|
| Models, Theoretical | 3 | 2015 | 3567 | 0.240 |
Why?
|
| Cluster Analysis | 6 | 2016 | 2700 | 0.230 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2006 | 302 | 0.230 |
Why?
|
| Metabolism | 1 | 2006 | 193 | 0.230 |
Why?
|
| Mitochondria | 2 | 2017 | 3619 | 0.230 |
Why?
|
| DNA Polymerase II | 2 | 2015 | 104 | 0.230 |
Why?
|
| Protein Biosynthesis | 3 | 2010 | 2100 | 0.230 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 2014 | 0.220 |
Why?
|
| Brain Neoplasms | 4 | 2015 | 9026 | 0.220 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2015 | 2821 | 0.220 |
Why?
|
| GTP Phosphohydrolases | 1 | 2007 | 517 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2016 | 2456 | 0.210 |
Why?
|
| Conserved Sequence | 5 | 2017 | 1162 | 0.210 |
Why?
|
| Sleep | 2 | 2016 | 4758 | 0.210 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2014 | 1113 | 0.210 |
Why?
|
| Genes, p53 | 3 | 2015 | 712 | 0.210 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 983 | 0.210 |
Why?
|
| Database Management Systems | 4 | 2012 | 257 | 0.200 |
Why?
|
| Binding Sites | 9 | 2018 | 6051 | 0.200 |
Why?
|
| raf Kinases | 2 | 2015 | 118 | 0.200 |
Why?
|
| Melanoma | 5 | 2015 | 5697 | 0.190 |
Why?
|
| Computer Simulation | 7 | 2018 | 6233 | 0.190 |
Why?
|
| Down-Regulation | 7 | 2015 | 2915 | 0.190 |
Why?
|
| Protein Binding | 11 | 2018 | 9345 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 3 | 2018 | 1963 | 0.190 |
Why?
|
| Prostatic Neoplasms | 10 | 2018 | 11106 | 0.180 |
Why?
|
| Genome-Wide Association Study | 7 | 2018 | 12661 | 0.180 |
Why?
|
| Protein Structure, Secondary | 5 | 2016 | 1229 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2014 | 2801 | 0.180 |
Why?
|
| Antineoplastic Agents | 5 | 2016 | 13635 | 0.180 |
Why?
|
| Amino Acid Sequence | 8 | 2017 | 13441 | 0.180 |
Why?
|
| Gene Amplification | 4 | 2014 | 1087 | 0.180 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2013 | 455 | 0.180 |
Why?
|
| Survival Analysis | 3 | 2013 | 10073 | 0.180 |
Why?
|
| ras Proteins | 5 | 2018 | 1054 | 0.170 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2015 | 789 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2018 | 15908 | 0.170 |
Why?
|
| Base Sequence | 12 | 2013 | 12421 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2018 | 2864 | 0.170 |
Why?
|
| DNA, Neoplasm | 2 | 2015 | 1743 | 0.160 |
Why?
|
| Genes, myc | 2 | 2011 | 390 | 0.160 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2018 | 34 | 0.160 |
Why?
|
| DNA Methylation | 8 | 2017 | 4391 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2016 | 2057 | 0.160 |
Why?
|
| Retinoblastoma Protein | 2 | 2014 | 671 | 0.160 |
Why?
|
| Sequence Analysis | 1 | 2019 | 240 | 0.160 |
Why?
|
| Microbial Consortia | 1 | 2018 | 33 | 0.150 |
Why?
|
| Breast Neoplasms | 8 | 2015 | 20988 | 0.150 |
Why?
|
| Cystadenocarcinoma, Serous | 2 | 2013 | 473 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2018 | 17878 | 0.150 |
Why?
|
| Genetic Association Studies | 4 | 2016 | 2734 | 0.150 |
Why?
|
| Epistasis, Genetic | 2 | 2017 | 350 | 0.140 |
Why?
|
| Rest | 3 | 2018 | 918 | 0.140 |
Why?
|
| DNA Repair | 3 | 2015 | 2043 | 0.140 |
Why?
|
| Epigenomics | 2 | 2013 | 942 | 0.140 |
Why?
|
| GTP-Binding Proteins | 2 | 2012 | 949 | 0.140 |
Why?
|
| Cell Cycle Proteins | 2 | 2011 | 3447 | 0.130 |
Why?
|
| Documentation | 3 | 2015 | 895 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2013 | 322 | 0.130 |
Why?
|
| Multigene Family | 3 | 2015 | 1076 | 0.130 |
Why?
|
| Integrin alpha Chains | 1 | 2016 | 95 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11736 | 0.130 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2016 | 162 | 0.130 |
Why?
|
| Casein Kinase II | 1 | 2016 | 122 | 0.130 |
Why?
|
| Nuclear Proteins | 5 | 2017 | 5789 | 0.130 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 242 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 988 | 0.130 |
Why?
|
| Phenotype | 8 | 2016 | 16571 | 0.130 |
Why?
|
| Animals | 39 | 2018 | 168201 | 0.130 |
Why?
|
| Genes, Mitochondrial | 1 | 2015 | 58 | 0.120 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2017 | 332 | 0.120 |
Why?
|
| Intestines | 2 | 2014 | 1909 | 0.120 |
Why?
|
| Glioma | 3 | 2015 | 3453 | 0.120 |
Why?
|
| Mice | 25 | 2018 | 81368 | 0.120 |
Why?
|
| Exonucleases | 1 | 2014 | 44 | 0.120 |
Why?
|
| Amino Acids | 3 | 2014 | 1717 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 2 | 2014 | 520 | 0.120 |
Why?
|
| Fibrosarcoma | 1 | 2016 | 308 | 0.120 |
Why?
|
| Electron Transport | 1 | 2015 | 210 | 0.120 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 242 | 0.110 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2007 | 410 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2016 | 1894 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.110 |
Why?
|
| Ecology | 1 | 2013 | 103 | 0.110 |
Why?
|
| Polymorphism, Genetic | 3 | 2014 | 4242 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1088 | 0.110 |
Why?
|
| Transcription Factors | 6 | 2017 | 12116 | 0.110 |
Why?
|
| Epigenesis, Genetic | 4 | 2013 | 3794 | 0.110 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 329 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 943 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 2895 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 456 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 1 | 2016 | 901 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 386 | 0.100 |
Why?
|
| Neuronal Plasticity | 2 | 2012 | 1433 | 0.100 |
Why?
|
| Bile Acids and Salts | 1 | 2014 | 393 | 0.100 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1550 | 0.100 |
Why?
|
| Gene Deletion | 4 | 2014 | 2661 | 0.100 |
Why?
|
| Quality Control | 1 | 2014 | 831 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2017 | 552 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2010 | 1608 | 0.090 |
Why?
|
| Bile Duct Neoplasms | 1 | 2017 | 605 | 0.090 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 480 | 0.090 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2011 | 76 | 0.090 |
Why?
|
| RNA-Binding Proteins | 4 | 2016 | 1890 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2013 | 1169 | 0.090 |
Why?
|
| Rhodopsin | 1 | 2011 | 203 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 717 | 0.090 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2011 | 103 | 0.090 |
Why?
|
| Trypsin | 1 | 2011 | 495 | 0.090 |
Why?
|
| Genome, Bacterial | 2 | 2014 | 783 | 0.090 |
Why?
|
| Nervous System Neoplasms | 1 | 2011 | 91 | 0.090 |
Why?
|
| Probability | 2 | 2013 | 2475 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 5 | 2017 | 5780 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2016 | 6474 | 0.090 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 937 | 0.090 |
Why?
|
| Neurofibromin 1 | 1 | 2012 | 190 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2014 | 571 | 0.090 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2013 | 262 | 0.090 |
Why?
|
| Protein Folding | 1 | 2014 | 870 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 4 | 2015 | 4739 | 0.090 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2011 | 233 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2013 | 2223 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 5304 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 3777 | 0.090 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2010 | 55 | 0.090 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2012 | 368 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2011 | 3608 | 0.090 |
Why?
|
| DNA Replication | 2 | 2014 | 1414 | 0.090 |
Why?
|
| Lymphoma, Follicular | 1 | 2014 | 457 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2011 | 1056 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2015 | 1084 | 0.080 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 194 | 0.080 |
Why?
|
| Female | 35 | 2018 | 392148 | 0.080 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2011 | 328 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 2 | 2010 | 471 | 0.080 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2007 | 1058 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2014 | 1687 | 0.080 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2013 | 304 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2013 | 1755 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2011 | 704 | 0.080 |
Why?
|
| RNA Interference | 2 | 2010 | 2830 | 0.080 |
Why?
|
| Skin Neoplasms | 5 | 2009 | 5812 | 0.080 |
Why?
|
| PDZ Domains | 1 | 2008 | 23 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 593 | 0.080 |
Why?
|
| Polyomavirus | 1 | 2009 | 234 | 0.080 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 682 | 0.080 |
Why?
|
| Lysine | 1 | 2013 | 993 | 0.080 |
Why?
|
| RNA Stability | 1 | 2010 | 320 | 0.080 |
Why?
|
| Fluorine Radioisotopes | 1 | 2011 | 418 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 11069 | 0.080 |
Why?
|
| Proto-Oncogene Proteins B-raf | 4 | 2016 | 2057 | 0.080 |
Why?
|
| Artificial Intelligence | 2 | 2015 | 2574 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 1257 | 0.080 |
Why?
|
| Biomedical Research | 3 | 2008 | 3426 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2014 | 5672 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3634 | 0.070 |
Why?
|
| Cell Proliferation | 7 | 2014 | 10432 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1788 | 0.070 |
Why?
|
| Cell Line | 9 | 2015 | 15576 | 0.070 |
Why?
|
| Insulinoma | 1 | 2008 | 121 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 2747 | 0.070 |
Why?
|
| Male | 35 | 2018 | 360358 | 0.070 |
Why?
|
| Polyomavirus Infections | 1 | 2009 | 194 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 254 | 0.070 |
Why?
|
| Genetics, Medical | 1 | 2010 | 334 | 0.070 |
Why?
|
| Poisson Distribution | 1 | 2008 | 504 | 0.070 |
Why?
|
| Glycolysis | 1 | 2011 | 835 | 0.070 |
Why?
|
| Endoribonucleases | 1 | 2008 | 228 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 502 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2014 | 1372 | 0.070 |
Why?
|
| Disease-Free Survival | 5 | 2015 | 6807 | 0.070 |
Why?
|
| Tumor Virus Infections | 1 | 2009 | 438 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 1250 | 0.070 |
Why?
|
| Polyadenylation | 2 | 2004 | 115 | 0.070 |
Why?
|
| Gene Rearrangement | 1 | 2011 | 1125 | 0.070 |
Why?
|
| Drug Design | 1 | 2011 | 1045 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 475 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 2 | 2018 | 164 | 0.070 |
Why?
|
| Software Design | 1 | 2006 | 171 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 841 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 2011 | 609 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 638 | 0.070 |
Why?
|
| Structural Homology, Protein | 2 | 2018 | 87 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2008 | 384 | 0.060 |
Why?
|
| Adenocarcinoma | 3 | 2013 | 6340 | 0.060 |
Why?
|
| Prognosis | 7 | 2016 | 29600 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2802 | 0.060 |
Why?
|
| Chromosome Aberrations | 2 | 2011 | 1768 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2011 | 2008 | 0.060 |
Why?
|
| Middle Aged | 19 | 2018 | 220584 | 0.060 |
Why?
|
| Drosophila melanogaster | 2 | 2005 | 1712 | 0.060 |
Why?
|
| Hematopoietic System | 1 | 2005 | 110 | 0.060 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2009 | 328 | 0.060 |
Why?
|
| Sirolimus | 1 | 2012 | 1533 | 0.060 |
Why?
|
| Neoplasm Metastasis | 5 | 2014 | 4910 | 0.060 |
Why?
|
| Disease | 1 | 2010 | 670 | 0.060 |
Why?
|
| Aged | 18 | 2018 | 169042 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3769 | 0.060 |
Why?
|
| RNA | 3 | 2019 | 2713 | 0.060 |
Why?
|
| Androgens | 1 | 2012 | 1285 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1755 | 0.060 |
Why?
|
| Cationic Amino Acid Transporter 1 | 1 | 2004 | 5 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2011 | 807 | 0.060 |
Why?
|
| Isotope Labeling | 2 | 2018 | 392 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 2689 | 0.060 |
Why?
|
| 3' Untranslated Regions | 4 | 2012 | 516 | 0.060 |
Why?
|
| Transfection | 2 | 2010 | 5766 | 0.060 |
Why?
|
| Quantitative Trait Loci | 3 | 2018 | 2112 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 2413 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 2569 | 0.060 |
Why?
|
| Radiopharmaceuticals | 2 | 2011 | 2650 | 0.060 |
Why?
|
| Self Report | 1 | 2016 | 3723 | 0.060 |
Why?
|
| Gene Library | 1 | 2007 | 1055 | 0.060 |
Why?
|
| Herpesviridae | 1 | 2005 | 104 | 0.060 |
Why?
|
| Prostate | 2 | 2011 | 1773 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 3077 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 1262 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2007 | 428 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 980 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 3 | 2012 | 4408 | 0.060 |
Why?
|
| Cell Division | 1 | 2011 | 4457 | 0.060 |
Why?
|
| Synapses | 2 | 2012 | 1755 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 632 | 0.060 |
Why?
|
| Neoplasms, Experimental | 3 | 2014 | 1226 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 3868 | 0.050 |
Why?
|
| International Cooperation | 1 | 2010 | 1421 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2004 | 205 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3031 | 0.050 |
Why?
|
| Electroencephalography | 3 | 2018 | 6237 | 0.050 |
Why?
|
| Reproducibility of Results | 6 | 2013 | 20074 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2016 | 4935 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2009 | 938 | 0.050 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2004 | 70 | 0.050 |
Why?
|
| Colorectal Neoplasms | 2 | 2013 | 6925 | 0.050 |
Why?
|
| Adult | 17 | 2018 | 220969 | 0.050 |
Why?
|
| Recurrence | 2 | 2014 | 8426 | 0.050 |
Why?
|
| Testis | 1 | 2006 | 792 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2016 | 4642 | 0.050 |
Why?
|
| Angiofibroma | 1 | 2003 | 55 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 2332 | 0.050 |
Why?
|
| Genes, Fungal | 1 | 2004 | 439 | 0.050 |
Why?
|
| Crystallography, X-Ray | 2 | 2018 | 1989 | 0.050 |
Why?
|
| Memory | 1 | 2012 | 2192 | 0.050 |
Why?
|
| Neoplasm Staging | 5 | 2016 | 11116 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2011 | 2894 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2015 | 4058 | 0.050 |
Why?
|
| Membrane Proteins | 4 | 2014 | 7847 | 0.050 |
Why?
|
| Apoptosis | 7 | 2011 | 9476 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 2222 | 0.050 |
Why?
|
| Codon, Nonsense | 2 | 2014 | 284 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2004 | 604 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2010 | 1125 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4570 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2008 | 871 | 0.050 |
Why?
|
| Cell Differentiation | 4 | 2011 | 11514 | 0.050 |
Why?
|
| Chlamydia trachomatis | 1 | 2003 | 239 | 0.050 |
Why?
|
| Aplysia | 2 | 2012 | 40 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2327 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2005 | 665 | 0.050 |
Why?
|
| Body Patterning | 1 | 2005 | 632 | 0.050 |
Why?
|
| Access to Information | 2 | 2016 | 316 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2005 | 721 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 1 | 2008 | 1086 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2007 | 1330 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2008 | 2930 | 0.040 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 13382 | 0.040 |
Why?
|
| Telomerase | 2 | 2016 | 744 | 0.040 |
Why?
|
| Protein Transport | 1 | 2006 | 1966 | 0.040 |
Why?
|
| Microsatellite Instability | 2 | 2014 | 716 | 0.040 |
Why?
|
| Repressor Proteins | 3 | 2011 | 2985 | 0.040 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2011 | 81 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 2007 | 4172 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2005 | 4611 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3145 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2446 | 0.040 |
Why?
|
| Virus Replication | 1 | 2007 | 2427 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2013 | 899 | 0.040 |
Why?
|
| Sarcoma | 1 | 2010 | 1800 | 0.040 |
Why?
|
| Ligands | 1 | 2006 | 3268 | 0.040 |
Why?
|
| Deuterium | 1 | 2018 | 106 | 0.040 |
Why?
|
| Brain | 3 | 2018 | 27101 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2010 | 473 | 0.040 |
Why?
|
| Point Mutation | 1 | 2004 | 1595 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 2010 | 6074 | 0.040 |
Why?
|
| Rats | 4 | 2007 | 23717 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2004 | 1077 | 0.040 |
Why?
|
| Data Mining | 2 | 2014 | 551 | 0.040 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2007 | 1158 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 9529 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2015 | 5091 | 0.040 |
Why?
|
| Transplantation, Heterologous | 3 | 2012 | 2382 | 0.040 |
Why?
|
| Kinetics | 1 | 2006 | 6370 | 0.040 |
Why?
|
| Natural Language Processing | 2 | 2004 | 1163 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2011 | 3735 | 0.040 |
Why?
|
| Positron-Emission Tomography | 2 | 2011 | 6483 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 2533 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 2872 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2018 | 593 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2011 | 3979 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 451 | 0.030 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 58894 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5319 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 2016 | 31 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2018 | 6224 | 0.030 |
Why?
|
| DNA | 1 | 2010 | 7196 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2015 | 1493 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2015 | 1745 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2016 | 12447 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2013 | 12943 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 2 | 2017 | 5367 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 129 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2004 | 2838 | 0.030 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 1639 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 4366 | 0.030 |
Why?
|
| Directed Molecular Evolution | 1 | 2016 | 161 | 0.030 |
Why?
|
| Neurons | 2 | 2012 | 9438 | 0.030 |
Why?
|
| Disease Progression | 4 | 2018 | 13495 | 0.030 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 1739 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 2 | 2010 | 1608 | 0.030 |
Why?
|
| Receptors, Androgen | 2 | 2012 | 1079 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2007 | 2317 | 0.030 |
Why?
|
| Skin | 1 | 2008 | 4473 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2003 | 1030 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2013 | 1964 | 0.030 |
Why?
|
| Chromatin | 2 | 2017 | 2955 | 0.030 |
Why?
|
| Genotype | 4 | 2014 | 12978 | 0.030 |
Why?
|
| Endometrial Neoplasms | 2 | 2014 | 1365 | 0.030 |
Why?
|
| Replication Origin | 1 | 2014 | 77 | 0.030 |
Why?
|
| DNA Polymerase III | 1 | 2014 | 51 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 1836 | 0.030 |
Why?
|
| Clostridium | 1 | 2014 | 100 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2014 | 70 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 77 | 0.030 |
Why?
|
| Hydrodynamics | 1 | 2015 | 168 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2016 | 4117 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2010 | 3087 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2015 | 350 | 0.030 |
Why?
|
| Germany | 2 | 2009 | 872 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 544 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2018 | 718 | 0.030 |
Why?
|
| Research Design | 2 | 2007 | 6174 | 0.030 |
Why?
|
| Succinate Dehydrogenase | 1 | 2014 | 145 | 0.030 |
Why?
|
| E2F3 Transcription Factor | 1 | 2013 | 36 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2013 | 56 | 0.030 |
Why?
|
| Zebrafish | 1 | 2005 | 3007 | 0.030 |
Why?
|
| Liver | 3 | 2017 | 7512 | 0.030 |
Why?
|
| Organisms, Genetically Modified | 1 | 2013 | 63 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2015 | 296 | 0.030 |
Why?
|
| Medical Records | 2 | 2013 | 1407 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 318 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2018 | 797 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2674 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 2 | 2016 | 2812 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2011 | 6126 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 638 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 154 | 0.030 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2012 | 34 | 0.030 |
Why?
|
| Taxoids | 1 | 2016 | 667 | 0.030 |
Why?
|
| Genes, erbB-2 | 1 | 2013 | 162 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2011 | 5034 | 0.030 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2012 | 31 | 0.030 |
Why?
|
| Ribosomes | 1 | 2016 | 500 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 569 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2010 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2011 | 3593 | 0.030 |
Why?
|
| Cell Physiological Phenomena | 1 | 2013 | 149 | 0.030 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2012 | 74 | 0.030 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2012 | 114 | 0.030 |
Why?
|
| Symbiosis | 1 | 2014 | 294 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 4571 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 180 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2013 | 3601 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2016 | 898 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2015 | 4512 | 0.020 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 7583 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 550 | 0.020 |
Why?
|
| Obesity | 1 | 2013 | 12933 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2012 | 270 | 0.020 |
Why?
|
| New York City | 1 | 2013 | 731 | 0.020 |
Why?
|
| COS Cells | 1 | 2013 | 1130 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2011 | 133 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 697 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2014 | 733 | 0.020 |
Why?
|
| Metagenome | 1 | 2014 | 448 | 0.020 |
Why?
|
| Genes | 1 | 2015 | 1823 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 373 | 0.020 |
Why?
|
| Survival Rate | 2 | 2016 | 12719 | 0.020 |
Why?
|
| DNA-Binding Proteins | 3 | 2017 | 9586 | 0.020 |
Why?
|
| Cadherins | 1 | 2015 | 901 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1088 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2011 | 269 | 0.020 |
Why?
|
| Intellectual Property | 1 | 2010 | 31 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2011 | 286 | 0.020 |
Why?
|
| Computers | 1 | 2013 | 591 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2013 | 8311 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2012 | 463 | 0.020 |
Why?
|
| Phylogeny | 2 | 2008 | 2806 | 0.020 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2011 | 210 | 0.020 |
Why?
|
| Cytokinesis | 1 | 2011 | 169 | 0.020 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2012 | 410 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2012 | 629 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 384 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 3842 | 0.020 |
Why?
|
| Half-Life | 1 | 2010 | 650 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 618 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 319 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2013 | 1336 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2013 | 709 | 0.020 |
Why?
|
| Viral Proteins | 2 | 2008 | 1799 | 0.020 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2009 | 55 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 1624 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2013 | 18937 | 0.020 |
Why?
|
| Glucose | 2 | 2011 | 4345 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2009 | 114 | 0.020 |
Why?
|
| Biochemistry | 1 | 2010 | 114 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 876 | 0.020 |
Why?
|
| Heterozygote | 1 | 2015 | 2780 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2014 | 1070 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2011 | 366 | 0.020 |
Why?
|
| Skin Abnormalities | 1 | 2008 | 59 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2010 | 473 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 2009 | 2913 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2011 | 749 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1703 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2009 | 369 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 1490 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 22115 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2008 | 153 | 0.020 |
Why?
|
| Feces | 1 | 2014 | 1490 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2008 | 105 | 0.020 |
Why?
|
| Pyrroles | 1 | 2014 | 1125 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 1404 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1483 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2008 | 432 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 2109 | 0.020 |
Why?
|
| Cholesterol | 1 | 2016 | 2903 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 5463 | 0.020 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2007 | 69 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 913 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1186 | 0.020 |
Why?
|
| Cell Movement | 2 | 2010 | 5200 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 458 | 0.020 |
Why?
|
| Cell Survival | 2 | 2008 | 5780 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2008 | 279 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2011 | 774 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2011 | 982 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 614 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1118 | 0.020 |
Why?
|
| Colitis | 1 | 2014 | 1234 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2009 | 575 | 0.020 |
Why?
|
| Education | 1 | 2008 | 534 | 0.020 |
Why?
|
| Indoles | 1 | 2014 | 1830 | 0.020 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2007 | 227 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2005 | 57 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2006 | 258 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3591 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2015 | 3998 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2009 | 1006 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 871 | 0.020 |
Why?
|
| Serotonin | 1 | 2009 | 1041 | 0.010 |
Why?
|
| Untranslated Regions | 1 | 2004 | 29 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2009 | 2625 | 0.010 |
Why?
|
| Immune System | 1 | 2010 | 791 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2013 | 2624 | 0.010 |
Why?
|
| Ecdysone | 1 | 2003 | 19 | 0.010 |
Why?
|
| Callithrix | 1 | 2004 | 95 | 0.010 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2004 | 115 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 9277 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2018 | 41457 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2007 | 850 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1545 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2849 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2009 | 3605 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2008 | 1027 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2008 | 14389 | 0.010 |
Why?
|
| Alleles | 1 | 2014 | 6861 | 0.010 |
Why?
|
| Breast | 1 | 2012 | 1963 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2003 | 264 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2010 | 1887 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2009 | 2195 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2004 | 294 | 0.010 |
Why?
|
| Genes, Essential | 1 | 2004 | 185 | 0.010 |
Why?
|
| Genes, Homeobox | 1 | 2003 | 286 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39063 | 0.010 |
Why?
|
| Overweight | 1 | 2013 | 2417 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4269 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2009 | 1333 | 0.010 |
Why?
|
| Time Factors | 3 | 2009 | 39913 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 927 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2015 | 42188 | 0.010 |
Why?
|
| Europe | 1 | 2008 | 3413 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2005 | 905 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 968 | 0.010 |
Why?
|
| Kidney | 1 | 2017 | 7045 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2013 | 9643 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2009 | 2764 | 0.010 |
Why?
|
| Imidazoles | 1 | 2007 | 1175 | 0.010 |
Why?
|
| Virus Latency | 1 | 2004 | 354 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1989 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4308 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2004 | 484 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 2509 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6338 | 0.010 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2011 | 1466 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2668 | 0.010 |
Why?
|
| Nervous System | 1 | 2003 | 545 | 0.010 |
Why?
|
| Nevus | 1 | 2002 | 205 | 0.010 |
Why?
|
| Adipocytes | 1 | 2007 | 1187 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 4764 | 0.010 |
Why?
|
| Retinitis Pigmentosa | 1 | 2004 | 397 | 0.010 |
Why?
|
| Reference Standards | 1 | 2004 | 1002 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2005 | 944 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1242 | 0.010 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2004 | 1111 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13245 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3705 | 0.010 |
Why?
|
| Young Adult | 2 | 2016 | 59179 | 0.010 |
Why?
|
| Research | 1 | 2007 | 1977 | 0.010 |
Why?
|
| Internationality | 1 | 2004 | 1000 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2007 | 2554 | 0.010 |
Why?
|
| Smoking | 1 | 2015 | 9050 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 14648 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 3356 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 2644 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 1386 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18381 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10754 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 7995 | 0.010 |
Why?
|
| Piperazines | 1 | 2007 | 2521 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 8601 | 0.010 |
Why?
|
| Adolescent | 3 | 2015 | 88234 | 0.010 |
Why?
|
| Child | 3 | 2015 | 80079 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2003 | 1528 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4354 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 7402 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 1698 | 0.010 |
Why?
|
| Multifactorial Inheritance | 1 | 2004 | 1380 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2009 | 2878 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2011 | 6634 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2007 | 1896 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2007 | 3309 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22148 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2007 | 3394 | 0.010 |
Why?
|
| Risk Factors | 2 | 2013 | 74115 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2004 | 1285 | 0.010 |
Why?
|
| United States | 2 | 2015 | 72272 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2008 | 6390 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18221 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8516 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2013 | 80566 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12966 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15251 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 15828 | 0.000 |
Why?
|